Propylthiouracil
RxNorm 8794
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 8794 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Propylthiouracil.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing propylthiouracil (medicinal product)
(Atom ID: 9261933)
INPrescribable
Ingredient (IN):
Propylthiouracil
(Atom ID: 12252208)
PTPrescribable
Designated preferred name (PT):
Propylthiouracil
(Atom ID: 281567)
FNPrescribable
Full form of descriptor (FN):
Propylthiouracil (substance)
(Atom ID: 281590)
PTPrescribable
Designated preferred name (PT):
Propylthiouracil-containing product
(Atom ID: 10819883)
Patient Education
Propylthiouracil
Propylthiouracil is used to treat hyperthyroidism (a condition that occurs when the thyroid gland produces too much thyroid hormone, speeding the body's metabolism, and causing certain symptoms) in adults and children 6 years of age or older. Propylthiouracil is in a class of medications called antithyroid agents. It works by stopping the thyroid gland from making thyroid hormone.
[Learn More]
* Please review the disclaimer below.